Access to antiretrovirals: effects of intellectual property protection
Developing countries have been, in most cases, sceptical about the implementation of intellectual property protection (IPP) with the premise that this policy will hurt the coverage of medicines because the price of the drugs will be substantially high. This claim has overlooked the long run effect o...
Autores principales: | , |
---|---|
Formato: | info:eu-repo/semantics/article |
Lenguaje: | Español |
Publicado: |
Universidad del Pacífico
2009
|
Acceso en línea: | https://revistas.up.edu.pe/index.php/apuntes/article/view/589 http://biblioteca-repositorio.clacso.edu.ar/handle/CLACSO/52920 |